Published in J Biol Chem on December 19, 2013
Mechanisms of group A Streptococcus resistance to reactive oxygen species. FEMS Microbiol Rev (2015) 0.89
Tissue tropisms in group A Streptococcus: what virulence factors distinguish pharyngitis from impetigo strains? Curr Opin Infect Dis (2016) 0.78
The FasX Small Regulatory RNA Negatively Regulates the Expression of Two Fibronectin-Binding Proteins in Group A Streptococcus. J Bacteriol (2015) 0.76
Epidemiology Analysis of Streptococcus pyogenes in a Hospital in Southern Taiwan by Use of the Updated emm Cluster Typing System. J Clin Microbiol (2015) 0.75
Blood Group Antigen Recognition via the Group A Streptococcal M Protein Mediates Host Colonization. MBio (2017) 0.75
Immunization with a streptococcal multiple-epitope recombinant protein protects mice against invasive group A streptococcal infection. PLoS One (2017) 0.75
Effects of penicillin and erythromycin on adherence of invasive and noninvasive isolates of Streptococcus pyogenes to laminin. Mem Inst Oswaldo Cruz (2015) 0.75
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
The global burden of group A streptococcal diseases. Lancet Infect Dis (2005) 13.58
Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev (1989) 7.80
Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol (1996) 6.28
Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol (2000) 5.28
DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med (2007) 4.35
Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog (2006) 3.68
Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis (2009) 3.51
A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog (1993) 2.99
Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol (2011) 2.81
Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis (2001) 2.51
M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell (2004) 2.46
Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun (2000) 2.34
Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem (1995) 2.31
Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun (2000) 2.24
Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg Infect Dis (2008) 2.14
Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Infect Immun (1997) 2.13
Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol (2004) 1.99
Streptococcal M protein. Sci Am (1991) 1.98
Pili mediate specific adhesion of Streptococcus pyogenes to human tonsil and skin. Cell Microbiol (2007) 1.97
Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002. Clin Infect Dis (2004) 1.95
Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes. Mol Microbiol (2006) 1.92
Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J Clin Invest (1998) 1.87
Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci U S A (1995) 1.86
Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc Natl Acad Sci U S A (1994) 1.85
M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. J Innate Immun (2009) 1.80
Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun (1996) 1.79
Trigger for group A streptococcal M1T1 invasive disease. FASEB J (2006) 1.77
Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence. Science (2008) 1.70
Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus. Infect Immun (1997) 1.60
Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone. J Infect Dis (2010) 1.57
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Pathol (1966) 1.55
M protein mediates streptococcal adhesion to HEp-2 cells. Infect Immun (1994) 1.48
Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A streptococcus. J Immunol (2003) 1.45
Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci. Ann Med (2002) 1.45
Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway. Mol Microbiol (2005) 1.41
New understanding of the group A Streptococcus pathogenesis cycle. Trends Microbiol (2007) 1.41
Group A streptococcal vaccines: facts versus fantasy. Curr Opin Infect Dis (2009) 1.37
A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol (1998) 1.36
Invasive group a streptococcal disease: epidemiology, pathogenesis and management. Drugs (2012) 1.35
Streptococcal M1 protein constructs a pathological host fibrinogen network. Nature (2011) 1.32
Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein. Mol Microbiol (2006) 1.29
A role for the fibrinogen-binding regions of streptococcal M proteins in phagocytosis resistance. Mol Microbiol (2000) 1.28
Re-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes. Cytogenet Cell Genet (1988) 1.26
Necrotizing fasciitis: pathogenesis and treatment. Expert Rev Anti Infect Ther (2005) 1.18
Fibrinogen cleavage by the Streptococcus pyogenes extracellular cysteine protease and generation of antibodies that inhibit enzyme proteolytic activity. Infect Immun (1999) 1.14
Selective modulation of superantigen-induced responses by streptococcal cysteine protease. J Infect Dis (2003) 1.12
Streptococcal M proteins and their role as virulence determinants. Clin Chim Acta (2010) 1.05
Serum opacity factor promotes group A streptococcal epithelial cell invasion and virulence. Mol Microbiol (2006) 1.03
Human pathogenic streptococcal proteomics and vaccine development. Proteomics Clin Appl (2008) 0.98
Human C4b-binding protein, structural basis for interaction with streptococcal M protein, a major bacterial virulence factor. J Biol Chem (2005) 0.96
The M protein of group A Streptococcus is a key virulence factor and a clinically relevant strain identification marker. Virulence (2011) 0.89
Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development. Mol Microbiol (2006) 0.89
Coiled-coil irregularities of the M1 protein structure promote M1-fibrinogen interaction and influence group A Streptococcus host cell interactions and virulence. J Mol Med (Berl) (2013) 0.87
Fibrinogen is localized on dark zone follicular dendritic cells in vivo and enhances the proliferation and survival of a centroblastic cell line in vitro. J Leukoc Biol (2007) 0.86
Fibrinogenolytic activity of a novel trypsin-like enzyme found in human airway. J Med Invest (1998) 0.86
The early interferon response of nasal-associated lymphoid tissue to Streptococcus pyogenes infection. FEMS Immunol Med Microbiol (2009) 0.86
Quantitative reagent-free detection of fibrinogen levels in human blood plasma using Raman spectroscopy. Analyst (2012) 0.79
[Lactoferrin and fibrinogen degradation products in saliva]. Lab Delo (1991) 0.77
HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell (2003) 9.12
NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature (2008) 6.13
ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science (2006) 6.00
Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell (2006) 5.97
DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol (2006) 5.22
DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med (2007) 4.35
IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature (2005) 4.31
HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest (2005) 3.77
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol (2011) 3.48
Identification of a bacterial type III effector family with G protein mimicry functions. Cell (2006) 3.47
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest (2007) 3.40
Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med (2005) 3.36
Participatory medicine: A home score for streptococcal pharyngitis enabled by real-time biosurveillance: a cohort study. Ann Intern Med (2013) 3.32
The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med (2008) 3.31
A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci U S A (2008) 3.27
Discovery of a widely distributed toxin biosynthetic gene cluster. Proc Natl Acad Sci U S A (2008) 3.20
Streptolysin S and necrotising infections produced by group G streptococcus. Lancet (2002) 3.02
A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science (2008) 2.96
Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J (2004) 2.81
Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol (2011) 2.81
Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol (2007) 2.76
Conformational flexibility in the multidrug efflux system protein AcrA. Structure (2006) 2.75
Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX. J Bacteriol (2003) 2.38
Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps. J Innate Immun (2010) 2.34
Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps. J Mol Med (Berl) (2009) 2.33
Mutational analysis of the group A streptococcal operon encoding streptolysin S and its virulence role in invasive infection. Mol Microbiol (2005) 2.30
Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe (2010) 2.28
Effect of a bacterial pheromone peptide on host chemokine degradation in group A streptococcal necrotising soft-tissue infections. Lancet (2004) 2.25
Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood (2009) 2.24
Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev (2014) 2.20
Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin Infect Dis (2011) 2.19
Human milk oligosaccharides protect bladder epithelial cells against uropathogenic Escherichia coli invasion and cytotoxicity. J Infect Dis (2013) 2.18
Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J Clin Invest (2003) 2.14
Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol (2010) 2.13
The C-type lectin fold as an evolutionary solution for massive sequence variation. Nat Struct Mol Biol (2005) 2.13
Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis. Arch Intern Med (2012) 2.09
Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest (2005) 2.07
D-alanylation of teichoic acids promotes group a streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J Bacteriol (2005) 2.04
Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother (2011) 2.00
Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol (2004) 1.99
Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11/Sec15 exocyst. Nature (2010) 1.95
Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proc Natl Acad Sci U S A (2004) 1.95
Discovery and characterization of sialic acid O-acetylation in group B Streptococcus. Proc Natl Acad Sci U S A (2004) 1.93
Imaging mass spectrometry of intraspecies metabolic exchange revealed the cannibalistic factors of Bacillus subtilis. Proc Natl Acad Sci U S A (2010) 1.90
Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med (Berl) (2007) 1.90
Three-dimensional secretion signals in chaperone-effector complexes of bacterial pathogens. Mol Cell (2002) 1.85
Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol (2005) 1.85
In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors. J Biol Chem (2003) 1.84
Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy. Mol Microbiol (2004) 1.83
M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. J Innate Immun (2009) 1.80
NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation. Proc Natl Acad Sci U S A (2009) 1.79
Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A. Proc Natl Acad Sci U S A (2014) 1.78
Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J Bacteriol (2006) 1.78
Trigger for group A streptococcal M1T1 invasive disease. FASEB J (2006) 1.77
TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood (2006) 1.74
Staphylococcus aureus Panton-Valentine leukocidin contributes to inflammation and muscle tissue injury. PLoS One (2009) 1.74
Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol (2003) 1.70
Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence. Science (2008) 1.70
Antibacterial drug leads targeting isoprenoid biosynthesis. Proc Natl Acad Sci U S A (2012) 1.69
A streptococcal protease that degrades CXC chemokines and impairs bacterial clearance from infected tissues. EMBO J (2006) 1.69
Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8. J Infect Dis (2002) 1.68
The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing. Cell Host Microbe (2008) 1.68
The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J (2006) 1.66
Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J Immunol (2002) 1.63
Cholera toxin disrupts barrier function by inhibiting exocyst-mediated trafficking of host proteins to intestinal cell junctions. Cell Host Microbe (2013) 1.61
Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect Immun (2005) 1.60
Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes. J Bacteriol (2006) 1.57
Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone. J Infect Dis (2010) 1.57
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother (2008) 1.56
A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria. Infect Immun (2005) 1.55
The antibiotic CJ-15,801 is an antimetabolite that hijacks and then inhibits CoA biosynthesis. Chem Biol (2012) 1.53
The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier. J Infect Dis (2009) 1.52
Identification of a streptolysin S-associated gene cluster and its role in the pathogenesis of Streptococcus iniae disease. Infect Immun (2002) 1.52
Global functional analyses of cellular responses to pore-forming toxins. PLoS Pathog (2011) 1.52
Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev Mol Med (2008) 1.52
The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses. BMC Microbiol (2008) 1.51
Structural and functional dissection of the heterocyclic peptide cytotoxin streptolysin S. J Biol Chem (2009) 1.50
Streptolysin O promotes group A Streptococcus immune evasion by accelerated macrophage apoptosis. J Biol Chem (2008) 1.49
The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion. J Exp Med (2009) 1.48
Late-onset group B streptococcal infection in identical twins: insight to disease pathogenesis. J Perinatol (2002) 1.44
Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J Infect Dis (2003) 1.44
An interesting presentation of pediatric tetanus. CJEM (2010) 1.40
Role of Staphylococcus aureus catalase in niche competition against Streptococcus pneumoniae. J Bacteriol (2008) 1.39
Innate immune-induced depletion of bone marrow neutrophils aggravates systemic bacterial infections. Proc Natl Acad Sci U S A (2009) 1.35
Color me bad: microbial pigments as virulence factors. Trends Microbiol (2009) 1.35
Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis. Proc Natl Acad Sci U S A (2014) 1.35
GW domains of the Listeria monocytogenes invasion protein InlB are SH3-like and mediate binding to host ligands. EMBO J (2002) 1.35
Innovations in host and microbial sialic acid biosynthesis revealed by phylogenomic prediction of nonulosonic acid structure. Proc Natl Acad Sci U S A (2009) 1.34
Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. J Exp Med (2009) 1.34
Top-down mass spectrometry on low-resolution instruments: characterization of phosphopantetheinylated carrier domains in polyketide and non-ribosomal biosynthetic pathways. Bioorg Med Chem Lett (2007) 1.33
Streptococcal M1 protein constructs a pathological host fibrinogen network. Nature (2011) 1.32
A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. FASEB J (2008) 1.31